Reading the descriptions of unmada in the Charaka Samhita can produce a sense of clinical recognition. The text records disturbed speech, inappropriate laughter or weeping, agitation, withdrawal, impaired memory and intellect, altered conduct, and difficulty regulating behaviour. These observations overlap with phenomena seen in modern psychiatry, including psychosis, mania, severe mood disturbance, catatonia, delirium, and some neurological or substance-related states. However, unmada is a classical Ayurvedic syndrome, not an ancient synonym for schizophrenia, bipolar disorder, or any single present-day diagnosis. Responsible comparison requires attention to similarities without claiming one-to-one equivalence.

Classical Definition and Scope

Charaka Samhita, Nidana Sthana 7 and Chikitsa Sthana 9 describe unmada as a broad disorder in which the functions of mind, intellect, memory, awareness, preferences, character, activity, conduct, and behaviour become disturbed. The online critical translation renders the term as frenzy, madness, or mental derangement and stresses that it represents a group of major mental disorders rather than one disease. The frequently quoted definition belongs to this classical framework; it should not be described as anticipating modern “multi-axis” diagnosis, because contemporary psychiatric systems use different concepts, criteria, and methods.

The Five Types Described by Charaka

Charaka Samhita, Nidana Sthana 7.3 lists five types: vata-dominant, pitta-dominant, kapha-dominant, sannipataja arising from the combined disturbance of all three doshas, and agantuja associated with exogenous causes in the classical worldview. These categories organise signs, causation, and treatment according to Ayurvedic theory. They are not validated substitutes for a psychiatric examination, medical work-up, toxicology assessment, or neurological evaluation.

Vataja Unmada

The classical description of vataja unmada includes constant wandering, irregular movements of the eyes and limbs, continuous irrelevant or incoherent speech, inappropriate smiling, laughing, dancing, singing or weeping, roughness, emaciation, and aggravation from factors considered to increase vata. This may resemble modern states marked by psychomotor agitation, disorganisation, mania, intoxication, delirium, or excited catatonia, but the signs are not specific enough to establish any of those diagnoses. Charaka’s treatment chapter begins the management of a vata-dominant presentation with unctuous measures and then modifies the plan according to obstruction, strength, digestion, and the patient’s overall condition.

Pittaja Unmada

Pittaja unmada is described with inappropriate anger, intolerance, agitation, threatening or assaultive behaviour, running about, bodily heat, a desire for shade, cold water or cooling food, and altered coloration of the eyes or complexion. The verse supports describing an activated, heated, irritable, and potentially dangerous presentation; it does not support equating pittaja unmada specifically with bipolar I disorder or substance-induced psychosis. In modern care, sudden aggression, severe insomnia, confusion, fever, intoxication, or a change in consciousness requires urgent assessment for psychiatric and medical causes.

Kaphaja Unmada

Kaphaja unmada includes immobility or remaining in one place, little speech, reduced movement, loss of appetite, preference for isolation, drowsiness or excessive sleep, salivation or nasal discharge, aversion to cleanliness, facial swelling, and dull or soiled-looking eyes. Some features may superficially resemble psychomotor slowing, depressive withdrawal, negative symptoms, medication effects, stupor, or catatonia. These similarities are descriptive only. A person with mutism, stupor, inability to eat or drink, marked drowsiness, or a rapid decline in self-care needs prompt clinical evaluation rather than dosha-based self-treatment.

Sannipataja Unmada

Sannipataja unmada presents with features of all three doshic types together. Nidana Sthana 7.7 states that this combined form is considered asadhya, and Chikitsa Sthana 9.15 describes it as severe and difficult to treat because the therapeutic principles may conflict. The text does not say that early cases are reliably curable, nor does it identify this category with schizoaffective disorder or “rapid cycling.” Those modern labels require their own diagnostic criteria.

Agantuja Unmada

Agantuja unmada is defined in the diagnostic chapter as having causes, prodromal signs, symptoms, distress, and responses to treatment that differ from dosha-origin unmada. Charaka discusses it through the religious and cultural language of deva, gandharva, yaksha, rakshasa, pishacha, ancestors, vows, conduct, and prajnaparadha. It is historically inaccurate to translate this entire category directly as trauma, infection, intoxication, or metabolic encephalopathy. A modern clinician should instead assess new psychotic or behavioural symptoms for psychiatric illness, medication effects, sleep deprivation, alcohol or drug use, neurological disease, infection, endocrine or metabolic disturbance, and other medical causes.

Comparison with Modern Psychiatry

The most defensible comparison is phenomenological: both systems notice changes in speech, perception, activity, sleep, emotional expression, memory, self-care, and social conduct. Modern psychosis is a collection of symptoms involving some loss of contact with reality and may occur in schizophrenia, bipolar disorder, severe depression, substance-related conditions, neurological disease, or other medical illness. The table therefore shows broad areas of overlap rather than diagnostic equivalence.

Classical Type Verified Classical Features Possible Modern Observations Important Limitation
Vataja Wandering, irregular movement, incoherent or irrelevant speech, inappropriate laughter, singing or weeping Agitation, disorganisation, mania, delirium, intoxication, or excited catatonia No one-to-one diagnosis
Pittaja Anger, agitation, threatening or assaultive behaviour, heat, desire for cooling Severe mood activation, psychotic agitation, intoxication, or medical delirium Urgent risk and medical assessment may be needed
Kaphaja Reduced speech and movement, isolation, excessive sleep, poor appetite, salivation Depressive slowing, negative symptoms, sedation, stupor, or catatonia Mutism or stupor is a medical priority
Sannipataja Combined features of all three doshic types Complex or mixed presentations Not equivalent to schizoaffective disorder
Agantuja Classically framed exogenous presentations with distinctive causes and signs Prompts a broad differential diagnosis in modern practice Classical spirit-language should not be relabelled as biomedical causation

What the Classical Treatment Chapter Actually Contains

Charaka Samhita, Chikitsa Sthana 9 presents an extensive, individualised programme rather than a simple herb list. It includes yukti-vyapashraya treatment selected according to dosha and patient strength, along with supportive or consoling measures, mental guidance associated with sattvavajaya, and religious practices appropriate to the text’s historical setting. The chapter also describes oleation, fomentation, emesis, purgation, basti, nasya, medicated ghee, massage, bathing, dietary progression after purification, and numerous specialised preparations. Several procedures are invasive, irritant, or otherwise unsafe outside trained clinical practice and should never be attempted at home.

Purification and Medicated Ghee

The treatment sequence is conditional, not universal. Charaka describes unctuous treatment for vata-dominant illness, emesis for selected kapha-dominant cases, and purgation for selected pitta-dominant cases, followed by a graded post-procedure diet. Formulations recorded in the chapter include Kalyanaka Ghrita and other medicated ghees. Their presence in a classical text verifies historical use; it does not establish efficacy for schizophrenia or acute psychosis by current clinical-trial standards. Panchakarma in a confused, medically unstable, dehydrated, restrained, pregnant, elderly, or heavily medicated patient may carry substantial risk and requires direct supervision by a qualified Ayurvedic physician working with the psychiatric team.

Brahmi: Correct Identity and Classical Properties

The Ayurvedic Pharmacopoeia of India, Part I, Volume II identifies Brahmi as the dried whole plant of Bacopa monnieri. Its monograph gives madhura, tikta and kashaya rasa; laghu and sara guna; shita virya; madhura vipaka; and actions including medhya and rasayana. It lists manasavikara among therapeutic uses and gives 1–3 g as the powder dose for the pharmacopoeial crude drug. This does not verify the original claims that Brahmi is the principal treatment for every unmada subtype, that 5–10 g powder or 20–30 ml juice twice daily is a standard psychiatric dose, or that 300 mg twice daily is a universally appropriate extract dose. Product strength and extract standardisation vary, and Brahmi should not be presented as an antipsychotic.

Shankhapushpi: Identity Matters

The same pharmacopoeial volume identifies Shankhapushpi as the whole plant of Convolvulus pluricaulis. It records katu, tikta and kashaya rasa; sara guna; shita virya; katu vipaka; and actions including medhya, rasayana, pittahara and kaphahara. The monograph lists manasaroga and apasmara as therapeutic uses and a powder dose of 3–8 g. It also notes that Clitoria ternatea and Evolvulus alsinoides are used as Shankhapushpi in some regions, making botanical identification important. No verified classical citation supports calling it the premier remedy specifically for vataja and pittaja unmada, and human evidence does not establish it as a treatment for psychosis.

Jatamansi, Ashwagandha and Guduchi

The online commentary accompanying Unmada Chikitsa includes Jatamansi and Ashwagandha in a compiled list of single drugs discussed in relation to unmada, but a compiled list is not proof that either herb treats modern psychosis. No verifiable classical passage or pharmacopoeial monograph was found supporting the original article’s precise claims about GABA modulation, rebound-free sedation, cortisol reduction in acutely agitated psychosis, or Guduchi as a specific remedy for pittaja unmada. Exact bedtime and twice-daily doses have therefore been removed. In psychosis, any herb should be selected only after reviewing the diagnosis, botanical identity, formulation, pregnancy, relevant liver or thyroid concerns, and possible interactions with antipsychotics, mood stabilisers, sedatives, anticonvulsants, and other medicines.

Diet and Supportive Care

Charaka includes dietary planning and a graded return from lighter to heavier food after purification. The treatment chapter specifically mentions cooling, sweet, and light food and drink in pitta-dominant management, while broader Ayurvedic practice individualises food according to digestion, strength, season, and dosha. The original rigid menu of warm-oily food for every vata presentation, coconut and bitter greens for every pitta presentation, and dry-pungent food for every kapha presentation was not supported by a cited verse and has been removed. In current care, regular meals, adequate fluids, sleep restoration, avoidance of alcohol and recreational drugs, and monitoring for inability to eat or drink are more immediately important than a dosha menu.

What Modern Research Can and Cannot Show

Human research on these herbs does not validate the classical subtypes or establish an Ayurvedic cure for psychosis. Systematic reviews of Bacopa monnieri have mainly examined memory and attention in adults without major cognitive impairment; they do not demonstrate antipsychotic efficacy. A small 12-week randomised placebo-controlled adjunctive study of a standardised Withania somnifera extract in people with schizophrenia reported signals for some symptoms, and a secondary analysis reported possible improvement in depression and anxiety scores. These early findings concern a particular extract used alongside standard treatment and are not grounds for replacing antipsychotic medication or generalising to all Ashwagandha products.

Mechanistic findings from cells or animals—such as effects on neurotransmitters, inflammation, or oxidative pathways—cannot by themselves prove clinical benefit in schizophrenia, bipolar mania, delirium, or acute psychosis. The original statements that Brahmi and Shankhapushpi act on central psychiatric drug targets, that Guduchi’s alkaloids “clear” pittaja psychosis, and that neuroinflammation forms a validated bridge between dosha theory and schizophrenia were overstated and have been removed.

Safety, Referral and Ethical Use

Psychosis may involve delusions, hallucinations, incoherent speech, disorganised behaviour, severe withdrawal, impaired self-care, or difficulty recognising reality. It can arise from psychiatric illness, sleep deprivation, prescribed medicines, alcohol or drugs, neurological disease, and other medical causes. Early assessment matters. Current evidence-based treatment commonly includes antipsychotic medication and may also include psychotherapy, family education, case management, supported work or education, and coordinated specialty care. Ayurvedic care, when desired, should be complementary and coordinated with a psychiatrist or other qualified mental-health professional.

Do not stop antipsychotics, mood stabilisers, benzodiazepines, anticonvulsants, or other prescribed medicines abruptly. Ashwagandha may cause drowsiness and gastrointestinal effects, has been linked rarely with liver injury, and may interact with sedatives, anticonvulsants, thyroid medicines, immunosuppressants, and medicines for diabetes or blood pressure. Safety data for many multi-herb and herbo-mineral products are limited, and product quality varies. Consult a qualified Ayurvedic practitioner and the treating healthcare provider before adding any herb or classical formulation.

Practical guidance: Do not begin a “Brahmi tea” routine as treatment for psychosis. A safer supportive action is to help the person obtain prompt professional assessment, keep the environment calm, reduce noise and confrontation, support regular food, fluids and sleep where possible, document all medicines and substances used, and remain alert for immediate danger. Seek emergency care when there is risk of self-harm or harm to others, extreme agitation, inability to eat or drink, severe confusion, fever, seizure, collapse, rapidly changing consciousness, or suspected overdose.

References

  1. Charaka Samhita — Unmada Nidana
  2. Charaka Samhita — Unmada Chikitsa
  3. Ayurvedic Pharmacopoeia of India
  4. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials (2012), PubMed
  5. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract (2014), PubMed
  6. Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study (2018), PubMed
  7. Effects of a standardized extract of Withania somnifera (Ashwagandha) on depression and anxiety symptoms in persons with schizophrenia participating in a randomized, placebo-controlled clinical trial (2019), PubMed
  8. Nimh (nimh.nih.gov)
  9. World Health Organization
  10. NCCIH
Tags: Classical Texts Manas Prakriti mental health Psychiatric Ayurveda Psychosis Unmada